Cash Flows
As of June 30, 2023 we had $7.6 million in cash. During the period from April 3, 2023 (commencement of operations) to June 30, 2023, we used $164.0 million in cash for operating activities, primarily as a result of funding of portfolio investments of $198.8 million, partially offset by repayment of portfolio investments of $5.8 million, and other operating activities of $29.0 million. Cash provided by financing activities was $171.6 million during the period, which was primarily the result of proceeds from the issuance of Shares in the Private Offering of $72.3 million and borrowings of $100.8 million, partially offset by repayments of borrowings of $1.5 million.
Financing Transactions
The Company intends to utilize leverage (including through the establishment of wholly-owned financing subsidiaries), to finance its investments and operations. The amount of leverage that the Company employs will be subject to the restrictions of the 1940 Act and the supervision of the Board. At the time of any proposed borrowing, the amount of leverage the Company employs will also depend on the Advisor’s assessment of market and other factors.
The Company is subject to limitations on leverage applicable to BDCs under the 1940 Act. As a BDC, with certain limited exceptions, the Company is only permitted to borrow amounts such that the Company’s asset coverage ratio, as defined in the 1940 Act, equals at least 150% after such borrowing. As of June 30, 2023, our asset coverage ratio, as defined under the 1940 Act as the ratio of our total assets (less all liabilities and indebtedness not represented by senior securities) to our outstanding senior securities, was 174.0%.
The Company intends to use leverage in the form of borrowings, including loans from certain financial institutions and the issuance of debt, and may form one or more wholly-owned financing subsidiaries in the future in connection therewith. The Company may also use leverage in the form of the issuance of preferred shares, but does not currently intend to do so, or by using reverse repurchase agreements or similar transactions and derivatives. The Company may use leverage for investments, working capital, expenses and general corporate purposes (including to pay dividends or distributions).
In determining whether to borrow money or issue debt on behalf of the Company, the Advisor will analyze, as applicable, the maturity, covenant package and rate structure of the proposed borrowings as well as the risks of such borrowings compared to the Company’s investment outlook. Any such leverage, if incurred, would be expected to increase the total capital available for investment by the Company.
On April 3, 2023, in connection with the acquisition of the Initial Portfolio, the Company, through SPV Facility I as borrower, entered into the MassMutual SPV I Facility with MassMutual, as the administrative agent and facility servicer, and the lenders party thereto from time to time. Under the MassMutual SPV I Facility, the lenders have made commitments of $200.0 million. The MassMutual SPV I Facility is secured by all of the assets of SPV Facility I and a pledge over 100% of the equity interest the Company holds in SPV Facility I. See “Note 4. Borrowings” in “Item 1. Unaudited Consolidated Financial Statements” in this Report for more information.
On May 1, 2023, the Company, through SPV Facility II as borrower, entered into the BMO Loan and Security Agreement with BMO to provide SPV Facility II with the BMO SPV II Credit Facility. As of June 30, 2023 BMO had made an initial commitment of $81.25 million under the BMO SPV II Credit Facility, with an accordion provision to permit increases to the total facility amount up to $100 million, subject to the satisfaction of certain conditions. The BMO SPV II Credit Facility is secured by a first priority security interest substantially all of the assets of SPV Facility II and a pledge over 100% of our equity interest in SPV Facility II. See “Note 4. Borrowings” in “Item 1. Unaudited Consolidated Financial Statements” in this Report for more information.
Subsequent to June 30, 2023, the Company amended the BMO Loan and Security Agreement, which increased the funded amount from the lenders under the BMO Loan and Security Agreement to $100,750,000 as of the amendment effective date and increased the maximum total commitments of the lenders under the accordion provision in the BMO Loan and Security Agreement to $125,000,000, in each case, subject to the satisfaction of certain conditions. See “– Recent Developments” below for more information.
As of June 30, 2023, the Company had outstanding borrowings of $99,500,135.
The Company may also from time to time enter into new credit facilities, increase the size of existing credit facilities or issue debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors.
Distributions and Distribution Reinvestment
There were no distributions declared or paid during the period from April 3, 2023 (commencement of operations) through June 30, 2023.
We expect to pay regular quarterly distributions commencing with the quarter ending September 30, 2023. Any distributions we make will be at the discretion of our Board, considering factors such as our earnings, cash flow, capital needs and general financial condition and the requirements of Delaware law. As a result, our distribution rates and payment frequency may vary from time to time.
28